| Diagnostic yield of repeat evaluation for asymptomatic microscopic hematuria after negative initial workup JS Pak, EY Wang, K Lee, LA Pina, JM McKiernan, CB Anderson Urologic Oncology: Seminars and Original Investigations 39 (5), 300. e1-300. e6, 2021 | 2 | 2021 |
| Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer JS Pak, CR Haas, CB Anderson, GJ DeCastro, MC Benson, ... Urologic Oncology: Seminars and Original Investigations, 2021 | 15 | 2021 |
| Erratum—Authorship order MD Galea, JS Pak, DE Chung CUAJ 15 (4), 2021 | | 2021 |
| The intravesical injection of highly purified botulinum toxin for the treatment of neurogenic detrusor overactivity (vol 14, pg E520, 2020) D Asafu-Adjei, A Small, G McWilliams, G Galea, JS Pak, DE Chung CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL 15 (4), E233-E233, 2021 | | 2021 |
| The intravesical injection of highly purified botulinum toxin for the treatment of neurogenic detrusor overactivity D Asafu-Adjei, A Small, G McWilliams, G Galea, DE Chung, JS Pak Canadian Urological Association Journal 14 (10), E520, 2020 | 4 | 2020 |
| A Urology Department's Experience at the Epicenter of the COVID-19 Pandemic JS Pak, CI Sayegh, MB Smigelski, JM McKiernan, KL Cooper Urology 144, 4-8, 2020 | 4 | 2020 |
| A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing … GJ DeCastro, W Sui, JS Pak, SM Lee, D Holder, MM Kates, RK Virk, ... The Journal of urology 204 (2), 247-253, 2020 | 28 | 2020 |
| Oncologic outcomes of complete transurethral resection prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer. JS Pak, CR Haas, H Vila Reyes, CB Anderson, GJ DeCastro, MC Benson, ... Journal of Clinical Oncology 38 (15_suppl), e17029-e17029, 2020 | 2 | 2020 |
| Bladder preservation for patients with bladder paragangliomas: case series and review of the literature EY Wang, JS Pak, RK Virk, CB Anderson, KA Healy, JA Lee, MC Benson, ... Urology, 2020 | 5 | 2020 |
| MP63-17 SEPSIS PROTOCOL IMPROVES OUTCOMES IN PATIENTS WITH STONE RELATED OBSTRUCTIVE PYELONEPHRITIS M Smigelski*, C Haas, C Sayegh, J Pak, O Shah The Journal of Urology 203 (Supplement 4), e961-e962, 2020 | | 2020 |
| MP73-09 EFFECTIVENESS OF COMBINATION CISPLATIN-BASED INTRAVESICAL CHEMOTHERAPY FOR BCG-REFRACTORY BLADDER CANCER H Vila-Reyes*, GJ Decastro, I Faiena, JS Pak, K Lee, G Li, CB Anderson, ... The Journal of Urology 203 (Supplement 4), e1124-e1124, 2020 | | 2020 |
| MP24-01 UTILITY OF REPEAT WORKUP FOR ASYMPTOMATIC MICROSCOPIC HEMATURIA AFTER INITIAL NEGATIVE EVALUATION JS Pak*, EY Wang, LA Pina Martina, K Lee, MP Rutman, KL Cooper, ... The Journal of Urology 203 (Supplement 4), e347-e347, 2020 | | 2020 |
| PD60-04 SURVIVAL ANALYSIS AND PREDICTORS OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE IN CLINICAL COMPLETE-RESPONDERS AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE … H Vila-Reyes*, K Lee, GJ Decastro, G Li, CR Haas, JS Pak, I Faiena, ... The Journal of Urology 203 (Supplement 4), e1274-e1274, 2020 | | 2020 |
| MP43-14 A PHASE 1 TRIAL OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) FOR THE TREATMENT OF NON-MUSCLE INVASIVE BCG UNRESPONSIVE UROTHELIAL CARCINOMA OF THE BLADDER GJ DeCastro*, C Anderson, J Pak, M Kates, B Buckley-Matura, W Sui, ... The Journal of Urology 201 (Supplement 4), e623-e623, 2019 | 4 | 2019 |
| Oncologic outcomes of definitive treatments for low-and intermediate-risk prostate cancer after a period of active surveillance MJ Whalen, JS Pak, D Lascano, D Ahlborn, JT Matulay, JM McKiernan, ... Clinical genitourinary cancer 16 (2), e425-e435, 2018 | 10 | 2018 |
| Gender Differences in the Urology Residency Match—Does It Make a Difference? CM Aisen, W Sui, JS Pak, M Pagano, KL Cooper, GM Badalato Urology 111, 39-43, 2018 | 21 | 2018 |
| Utilization trends and outcomes up to 3 months of open, laparoscopic, and robotic partial nephrectomy JS Pak, JJ Lee, K Bilal, M Finkelstein, MA Palese Journal of Robotic Surgery 11 (2), 223-229, 2017 | 24 | 2017 |
| Utilization trends and short-term outcomes of robotic versus open radical cystectomy for bladder cancer JS Pak, JJ Lee, K Bilal, M Finkelstein, MA Palese Urology 103, 117-123, 2017 | 23 | 2017 |
| A phase I trial for the use of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) in the treatment of BCG-refractory nonmuscle invasive urothelial carcinoma of the bladder. GJ DeCastro, W Sui, JS Pak, CT Abate-Shen, SM Lee, CB Anderson, ... Journal of Clinical Oncology 35 (6_suppl), 313-313, 2017 | 16* | 2017 |
| Prevalence of research publication misrepresentation among urology residency applicants and its effect on match success JS Pak, MJ Pagano, KL Cooper, JM McKiernan, GM Badalato Urology 99, 5-9, 2017 | 17 | 2017 |
